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1, INTRODUCTION 
Phosphorylation is a universal regulatory mechanism 
of cellular processes including growth, differentiation 
and transformation, In the adenylate ycIasc (AC) sys- 
tern, the CAMP-dependent protein kinase (CAMP-PK) 
is activated by a concerted series of events initiated by 
the binding of hormone to receptor at the external sur- 
face of the plasma membrane [ 1,2], CAMP production 
by AC leads to the elevation of intracellular CAMP 
levels, and dissociation of the CAMP-PK holoenzyme 
complex to release the active catalytic (C-) subunit [3,4]. 
A variety of cellular proteins serve as substrates for 
phosphorylation by the kinase, resulting in the modula- 
tion of a number of metabolic pathways and gene regu- 
lation [1,2]. Down-regulation or desensitization begins 
at the level of the receptor [5-71, but occurs at all stages 
of the above [2,5,8], including CAMP-PK itself [9,10]. 
The cAMP-PK [5-7,11,12] as well as the ,&adrenergic 
receptor kinase [13,14] are capable of phosphorylating 
the ,&adrenergic receptor, thereby regulating its trans- 
ducing capacity and/or endocytosis, 
This study examines the effect of in vivo activation of 
CAMP-PK on the vasoprcssin &-type receptor of LLC- 
PK, renal cpithcliai cells [lS] which possess distinct 
receptors for vasoprcssin and calciconin, both of which 
activate AC [16,17]. In addition to agents elevating in- 
traccllular CAMP, phorbol csccrs stimulate LLC-PKI 
cells lo produce urokinase-type plasminogen activator 
by a CAMP-independent Ca’+Jphospholipid-dependent 
protein kinase (PK-C) -mediated pathway [18,19]. Here 
we examine cells of the LLC-PKI cell line, and those of 
the FIB4 mutant, which possesses normal amounts of 
CAMP-PK C-subunit, but only aboGt 10% wild-type ac- 
tivity f 18,20), Treatments activating CAMP-PK or PK- 
C to differing extents were examined for their effects on 
V2-receptor binding. We demonstrate a nega.tive cor- 
relation between CAMP-PK activation and both VZ- 
receptor number and internalization. 
2. MATERIALS AND METHODS 
2 I I t Mareriols 
5’-[y-3LPJATP and [~WJArgs-vasopressin (AVP) were from 
Amcrsham, and phosphocellulose paper (P-81) from Whatman. All 
Other materials were from previously described sources [17,21]. 
2.2. Cell culrure 
Correspondetm oddms: D.A. Jans, c/o Dr. F. Fahrenholz, Max 
Planck Institut fiir Biophysik, Kennedyallce 70, D-6000 Frankfurt am 
Main 70, Germany. Fax: (49) (69) 630 3423 
The LLC-PKI pig kidney epithelial cell line [IS] and the FIB4 mu- 
tant [18,20) were cultured as described previously [17]. 
2,3. Enzyme us.wj~s 
Abbreviuriom: CAMP-PK, CAMP-dependent protein kinase or 
ATP I protein phosphotransferase (EC 2.7.1,37); CAMP, adenosine 
Extracts for the assay of CAMP-dependent protein kinasc (CAMP- 
PK) catalytic activity were prepared and assayed using Kemptide (L- 
3 ‘,5 ‘monophosphate; BrcA, 8-bromo-CAMP; AC, adcnylate cyclase 
or ATP pyrophosphatelyase (cyclicizing, EC 4.6.1.1); AVP, Arg*- 
R-R-A-S-A-G) as a substrate 117,211. The CAMP-PK activity ratio ex- 
presses rhe C-subunit activity present in cell extracts (assayed in the 
vasoprcssin; IBMX, 1-isobutyl-3-methylxanthine absence of CAMP) relative to the total stimulatable activity (assayed 
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3. RESULTS 
WC initially modified our binding assay for LLGPK, 
ccllt in suspension [I71 to cplantitntc the relative con- 
tribution of receptor internalization/recycling etc. to 
total maximal Y&receptor bi.nding activity (section 2). 
Half-maximal binding at 30eC and 4’C was achieved at 
2.2 f 0,l min (Fig- 1, squares) and lg.6 f 1.4 min 
(Fig. 1, closed circles) respectively (mean & SEM for 
n > 3). Lignnd internalization, estimated using a pW 3 
treatment subsequent to binding, was half-maximal at 
6.9 f 1.6 min at 30°C (Fig. 1, triangles), No intcr- 
nalizntion was observed at 4’C (Fig. 1, empty circles). 
Maximal specific binding at 4OC (64 fmol/lO” cells) 
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time tmin) 
Fig. 1. Time course OF [‘HIAVP specific binding and internalization 
in EDTA-suspended LLC-PKI cells. Total specific binding at 30°C 
(S--e) or 4°C (S--a), or internalization at 30°C (F--V) or 4OC 
@----O) was determined as described in section 2. Results are the 
means From a single typical experiment For which the SEM was less 
than 11% the value of the mean. Maximal binding was achieved at 
40.0 -L 3.4 and 10.8 + 2.1 min (mean f SEM, n > 3) at 4°C and 
3O”C, respectively; internalization was maximal at 15.7 2 3.3 min. 
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represents the number of binding sites at steady state 
(no conrribucion of internalization or rceeptor cy- 
cling/recycling); and accounted for about 53alo f total 
maximal binding at WC (120 fmol/106 eclls). Inter- 
nalization at 30°C (40 fmol/lO” cells) accounreci for a 
further 33%, which is comparable to that observed in 
other systems (e.g, [28]). 
Short trypsin treatment (0.25ol0, 5 min, 4OC) subse- 
quent to binding was not as effective as pH 3 treatment 
in removing non-internalized ligand, since 29”/o of 
ligand bound at 4*C remained cell-associated (Table I), 
Cells pretreated at pH 3 prior to binding showed no 
reduction of either maximal specific [3H]AVP binding 
nor internalization at 4°C or 30°C (Table I), indicating 
that pH 3 treatment did not irreversibly denature the 
V,-receptor. In contrast, short trypsin pretreatment 
reduced maximal binding by 33% or 56% at 4°C or 
3O”C, respectively. NaN3, which inhibits energy- 
dependent processes uch as rcccptor endocytosis, did 
not affect the number of AVP-binding sites (4’C bind- 
ing), but reduced internalization by 5 1% compared to 
untreated cells (Table I). 
3.1. L3H_/4 W bindkg and ~~ter~Qiiz~~i~n in LLC-PKI 
cells treated with ugem elevating intracelluluc 
CAMP Ievels 
LLC-PK! cells were pretreated with the CAMP ana- 
logue 8-bromo-CAMP (BrcA) for either 1 h or 17 h, 
and then CAMP-PK activation (Table II) and maxima1 
specific [‘H]AVP binding and internalization were 
determined (Fig. 2). 1 h treatment (CAMP-PK activity 
ratio of 0.42) resulted in a marked reduction of both 
AVP internalization (54% reduced compared to un- 
treated cells) and binding at 4°C (35070 decreased). 17 h 
treatment (conditions of down-regulated CAMP-PK; 
activity ratio of 0.24) also induced a reduction in inter- 
nalization (5 1070 reduced compared to untreated con- 
rrol). Reduced AVP inrcrncsliaatian did nor ~ppcsr NJ 
rcsulr from an altered Vz-receptor affinity for ligand 
(nor shown). 
Results were compared to cells pretreated for 1 h or 
48 h with 3 x IO”” M phorbol-tnyristate acetate (PMA), 
frcatmcnts which induce activation and down-regulation 
b°C -I 
LLC-PK, 
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Fig. 2. Maximal specific [“H]AVP bindinE and internalization in cc!is 
of the LLC-PKI and CAMP-PK mutant FIW cell lines. Total specific 
binding ( q ) and internalization (a) were determined after 30 and 
60 min at 30°C and 4OC, respectively, on cells pretreated as indicated. 
The results shown are the means with SEM shown for more than 3 ex- 
periments performed in duplicate. 
respectively of PM-C [18,19,29], Compared to untreated 
cells, PMA-trcaccd cells exhibited slightly increased in- 
ternalization at 30*Cand binding at 4’C. Total binding 
at 30°C was rsxentially comparable for all oft hc various- 
ly treated and untreated cells, with the possible xcep- 
tion of PK-C-down-regulated cells, which showed 19% 
higher total binding. 
The data for LLC-PK, cells under the above various 
conditions (from Table II and Fig. 2) revealed anegative 
correlation (v = -0.92, x = 65.8, y = -96.7, /I = S) bc- 
fween the cAMP-PM activity ratio and the number of 
Vz-receptors at steady state (binding at 4OC), A negative 
correlation (I’ = -0.89, x = 47. I, y F -69.6, 11 = 5) was 
also observed for CAMP-PK activity ratio and AVP in- 
ternalization. 
3.2. flYJAW binding and internulization in the 
CAMP-PK C-subunit r?zutm FIB4 
The FIB4 mutant [20] was similarly analyzed for 
AVP binding and internalization. FIB4 cells, with or 
without BrcA pretreatment, showed total binding at 
30°C essentially comparable to that of LLC-PKI ceils 
(Fig. 2). The extent of CAMP-PK activation (CAMP-PK 
activity ratio) upon BrcA treat,ment (I h or 17 h) was 
also comparable for both cell lines (Table II), although 
the absolute CAMP-PK activities were largely different 
due to the C-subunit mutation of FIB4. However, max- 
imal specific [3H]AVP internalization was markedly 
lower (more than 40% reduced), as was steady state 
binding activity (4OC) (50% reduced) compared to un- 
treated LLC-PK, cells. FIB4 cells thus largely resem- 
bled BrcA-treated (down-regulated) LLC-PKI cells in 
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their [rH]AVP rready IWF: binding and lnre~nali%~tion 
(Fig. 2). 
cellular cAMP levels have an effect on AVP-binding, 
LLC-PKI cells were prerrerred with either forxkolin 
(AC ncrivarot) or salmon calcitonin for 17 h snd eam- 
pared to Brch-treated or uncrrated fells for [“WIAVP 
binding (Fig, 3). All n,goniet pretrcatmcntd reduecd 
[‘I-I] AVP in~ernali2a~iol~ (Fig. S), indicating tkar agcntrc 
ocher than BreA which bring about cAMP-PK do&%- 
regulation [IO] also effect a reduction in V~~~pfor in- 
rernaliration. 
4. IXSCUSSION 
The results here suggest a role fur the CAMP-PK in 
regulating liynnd binding and inrcrnalization by the VZ- 
receptor of LLC-PKt cells. Trcatmcnlf resulting in rhe 
stimulation and subsequent down-regulation of CAMP- 
PK markedly reduced the steady state V~~cp~or num- 
ber and internalization. Interestingly, the CAMP-PK C- 
subunit mutant FIB4 also showed a low steady srare re- 
ceptor number and internalization, Activation of the 
CAMP-PK by BrcA (and probably also by vasopressin 
itself) appears to effect endocytosis of plasma mcm- 
branc receptors even though they arc not occupied by 
ligand, and concomitant reduction in ligand-dcpcndcnt 
internalization, presumably mediated by phosphoryla- 
tion, That hcterologous hormone (calcitonin)- or 
I ’ I , 1 1 , 
1 ’ L 1 1 * 
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Fig. 3. Influenceof agents elevating intracellular CAMP on I’H]AVP 
internalization in LLC-PKI cells. The timecourse of internalization at 
30°C was followed in LLC-PKI cells which had been pretreated for 
17 h without (o-d) or with 1 mM BrcA (V--V), IO ~4ctM forskolin 
( D---D), or 30 nM salmon calcitonin (gd), Results are the means 
from a single typical experiment for which the SEM was less than 12% 
the value of the mean. 
O\her kinarts may alsa hwc an int’luencs on Ww 
reprsr function. P&C pl~y’~ a rale in dcPenrririxarion in 
rhc @adrener$ic ry~rn [5,31], bur we obscrvrid no 
marked eft”rcr of PMA an Va.-inrernalizution here, and 
an elevk\rcd rather than rcducrd arcady state VZ-receptor 
number (9x Fig. 21, In the eaxe a$ xhc recepr0r4 for the 
~umour necro%ia thctor and EGF, PMA ind~iecs rccep- 
tar down-regulation in the absence af lipand, due to a 
reduction in the number of plasmn membrane reecptorr 
[32]. lnrcrcstingly, 0~i.u pnrallcls rhc effceta of’ cAMI> 
agonists on the Vp-receptar. Further examination of the 
various complex fecdbeck mcchsnisms usin in viro 
systems, together with murant% affected in specific COW 
ponents of signal lransdutxion, sllould assist in 
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